Eli Lilly and Company
CL ˙ SNSE ˙ US5324571083
SecurityCL:LLY / Eli Lilly and Company
InstitutionOpus Capital Group, LLC
Latest Disclosed Ownership895 shares
Latest Disclosed Value $ 823
Opus Capital Group, LLC reports 16.82% decrease in ownership of LLY / Eli Lilly and Company

On April 30, 2026 - Opus Capital Group, LLC filed a 13F-HR form disclosing ownership of 895 shares of Eli Lilly and Company (CL:LLY) valued at $823 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 1,076 shares of Eli Lilly and Company. This represents a change in shares of -16.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Lilly Eli COM 532457108 895 -181 -16.82 1 -100.00 0.0885
2026-01-30 2025-12-31 13F Lilly Eli COM 532457108 1,076 -67 -5.86 1 0.1252
2025-10-31 2025-09-30 13F Lilly Eli COM 532457108 1,143 -36 -3.05 1 0.0980
2025-07-31 2025-06-30 13F Lilly Eli COM 532457108 1,179 0 0.00 1 0.1100
2025-04-30 2025-03-31 13F Lilly Eli COM 532457108 1,179 -1,735 -59.54 1 -100.00 0.1254
2025-01-31 2024-12-31 13F Lilly Eli COM 532457108 2,914 -6,195 -68.01 2 -75.00 0.2858
2024-10-31 2024-09-30 13F Lilly Eli COM 532457108 9,109 8,006 725.84 8 1.0086
2024-07-31 2024-06-30 13F Lilly Eli COM 532457108 1,103 -17 -1.52 1 0.1424
2024-04-26 2024-03-31 13F Lilly Eli COM 532457108 1,120 -159 -12.43 1 0.1272
2024-01-31 2023-12-31 13F Lilly Eli COM 532457108 1,279 -12 -0.93 1 0.1212
2023-10-31 2023-09-30 13F Lilly Eli COM 532457108 1,291 -125 -8.83 1 0.1229
2023-07-31 2023-06-30 13F Lilly Eli COM 532457108 1,416 19 1.36 1 0.1149
2023-04-24 2023-03-31 13F Lilly Eli COM 532457108 1,397 -24 -1.69 0 0.0880
2023-01-18 2022-12-31 13F Lilly Eli COM 532457108 1,421 -55 -3.73 1 -100.00 0.1008
2022-10-31 2022-09-30 13F Lilly Eli COM 532457108 1,476 -10 -0.67 477 -1.04 0.1034
2022-07-29 2022-06-30 13F Lilly Eli COM 532457108 1,486 -521 -25.96 482 -16.17 0.0978
2022-04-25 2022-03-31 13F Lilly Eli COM 532457108 2,007 -3 -0.15 575 3.60 0.1122
2022-01-31 2021-12-31 13F Lilly Eli COM 532457108 2,010 3 0.15 555 19.61 0.1148
2021-10-29 2021-09-30 13F Lilly Eli COM 532457108 2,007 -750 -27.20 464 -26.70 0.1051
2021-07-29 2021-06-30 13F Lilly Eli COM 532457108 2,757 -213 -7.17 633 14.05 0.1437
2021-04-28 2021-03-31 13F Lilly Eli COM 532457108 2,970 -567 -16.03 555 -7.04 0.1333
2021-01-29 2020-12-31 13F Lilly Eli COM 532457108 3,537 0 0.00 597 13.93 0.1517
2020-10-30 2020-09-30 13F Lilly Eli COM 532457108 3,537 -565 -13.77 524 -22.14 0.1531
2020-07-31 2020-06-30 13F Lilly Eli COM 532457108 4,102 -40 -0.97 673 17.04 0.2060
2020-04-30 2020-03-31 13F Lilly Eli COM 532457108 4,142 -339 -7.57 575 -2.38 0.2034
2020-01-31 2019-12-31 13F Lilly Eli COM 532457108 4,481 1,456 48.13 589 74.26 0.1733
2019-11-04 2019-09-30 13F Lilly Eli COM 532457108 3,025 0 0.00 338 0.90 0.1041
2019-08-08 2019-06-30 13F Lilly Eli COM 532457108 3,025 -2,065 -40.57 335 -49.24 0.1004
2019-04-30 2019-03-31 13F Lilly Eli COM 532457108 5,090 0 0.00 660 11.86 0.1761
2019-02-07 2018-12-31 13F Lilly Eli COM 532457108 5,090 5,090 590 0.1229
2016-05-05 2016-03-31 13F Eli Lilly COM 532457108 0 0 0 0.0000
2015-08-05 2015-06-30 13F Eli Lilly COM 532457108 0 -7,155 -100.00 0 -100.00
2015-05-07 2015-03-31 13F Eli Lilly COM 532457108 7,155 0 0.00 520 5.48 0.0823
2015-02-05 2014-12-31 13F Eli Lilly COM 532457108 7,155 0 0.00 493 6.25 0.0715
2014-11-10 2014-09-30 13F Eli Lilly COM 532457108 7,155 -7,155 -50.00 464 -47.87 0.0638
2014-08-12 2014-06-30 13F Lilly Eli COM 532457108 14,310 0 0.00 890 5.70 0.0618
2014-04-30 2014-03-31 13F Lilly Eli COM 532457108 14,310 0 0.00 842 15.34 0.0599
2014-01-31 2013-12-31 13F Lilly Eli COM 532457108 14,310 7,160 100.14 730 102.78 0.0403
2013-10-31 2013-09-30 13F Lilly Eli COM 532457108 7,150 0 0.00 360 2.56 0.0204
2013-08-01 2013-06-30 13F Lilly Eli COM 532457108 7,150 7,150 351 0.0215
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.